Pending

Shrinking lung syndrome in pediatric systemic lupus erythematosus
Interferon-alpha activates interleukin-1 receptor-associated kinase 1 to induce regulatory T-cell apoptosis in patients with systemic lupus erythematosus
Th cytokine profile in childhood-onset systemic lupus erythematosus
Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’
Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study
Pure red cell aplasia in systemic lupus erythematosus, a nationwide retrospective cohort and review of the literature
Glycol chitosan-based tacrolimus-loaded nanomicelle therapy ameliorates lupus nephritis
Immune profiling of lupus miliaris disseminatus faciei and successful management with anti-TNF therapy
Azithromycin alleviates systemic lupus erythematosus via the promotion of M2 polarisation in lupus mice
Gut Microbiota in Lupus: a Butterfly Effect?
5-aminolevulinic acid combined with sodium ferrous citrate ameliorated lupus nephritis in a mouse chronic graft-versus-host disease model
Etanercept prevents TNF-alpha mediated mandibular bone loss in FcgammaRIIb-/- lupus model
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus
TRIM27 contributes to glomerular endothelial cell injury in lupus nephritis by mediating the FoxO1 signaling pathway
cGAS-STING Pathway Does Not Promote Autoimmunity in Murine Models of SLE
Weighted Gene Co-expression Network Analysis Reveals Different Immunity but Shared Renal Pathology Between IgA Nephropathy and Lupus Nephritis
Associations between glucocorticoids, antiphospholipid antibodies and femur head necrosis in patients with SLE: a directed acyclic graph-based multicentre study
Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: A meta-analysis
Exercise alleviates symptoms of CNS lupus
Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor
The Benefits of Complement Measurements for the Clinical Practice
Detection of Anti-C3b Autoantibodies by ELISA
Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus
Lupus Cerebritis Refractory to Guideline-Directed Therapy: A Case Report
One year in review 2021: systemic lupus erythematosus
The CXCL13 chemokine serves as a potential biomarker to diagnose systemic lupus erythematosus with disease activity
Lupus erythematosus associated with erythema multiforme or Rowell’s syndrome. Report of one case
Contribution of Clinically Indicated Repeat Renal Biopsy in Indian Patients with Lupus Nephritis
Deposition of Immune Complexes in Gingival Tissues in the Presence of Periodontitis and Systemic Lupus Erythematosus
Role of biomarkers in the diagnosis and prognosis of patients with cutaneous lupus erythematosus
The CLASI, a validated tool for the evaluation of skin disease in lupus erythematosus: a narrative review
Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis
Successful treatment of refractory cystitis associated with systemic lupus erythematosus with Belimumab
Transcriptomic studies of systemic lupus erythematosus
Recent Insight on the Management of Lupus Erythematosus Alopecia
COVID-19 Vaccination in Rheumatic Disease Patients
Uncoupled bone remodeling is characteristic of bone damage in premenopausal women with new-onset systemic lupus erythematosus
Psychometric properties of FACIT-Fatigue in systemic lupus erythematosus: a pooled analysis of three phase 3 randomised, double-blind, parallel-group controlled studies (BLISS-SC, BLISS-52, BLISS-76)
Biologics and systemic lupus erythematosous : new insights and perspectives
Cardiovascular Considerations in Anesthetic Management for a Patient With Antiphospholipid Syndrome and Decreased Cardiac Function: A Case Study
LONG TERM RENAL SURVIVAL OF PEDIATRIC PATIENTS WITH LUPUS NEPHRITIS
Pruritus as a Distinctive Feature of Type 2 Inflammation
Urine soluble urokinase plasminogen activator receptor as a potential biomarker of lupus nephritis activity
ALPN-101 in Systemic Lupus Erythematosus
Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients
Bilateral periorbital oedema revealed as systemic lupus erythematosus in a young male
An Update for Mesenchymal Stem Cell Therapy in Lupus Nephritis
Predictors of renal flares and long-term renal outcome in patients with lupus nephritis: results from daily clinical practice
Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention
Targetoid lesions in a patient with systemic lupus erythematosus
Femoral Head Osteonecrosis in Systemic Lupus Erythematosus: Total Hip Arthroplasty Outcomes and Considerations
CDK4/6 inhibitor palbociclib reduces inflammation in lupus-prone mice
An elevated polyclonal free light chain level reflects a strong interferon signature in patients with systemic autoimmune diseases
Anti-TWEAK Antibody Alleviates Renal Interstitial Fibrosis by Increasing PGC-1alpha Expression in Lupus Nephritis
LINC00176 facilitates CD4(+)T cell adhesion in systemic lupus erythematosus via the WNT5a signaling pathway by regulating WIF1
A STING antagonist modulating the interaction with STIM1 blocks ER-to-Golgi trafficking and inhibits lupus pathology
PECULIARITIES OF BONE MINERAL DENSITY IN WOMEN OF DIFFERENT REPRODUCTIVE AGE WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Iguratimod ameliorates nephritis by modulating the Th17/Treg paradigm in pristane-induced lupus
TRIM10 binds to interferon-α/β receptor 1 to negatively regulate type I interferon signal transduction
Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review
Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus
Respiratory Manifestations in Systemic Lupus Erythematosus
Autoimmune Complications in Hematologic Neoplasms
Erythropoietin Protects against Diffuse Alveolar Hemorrhage in Mice by Regulating Macrophage Polarization through the EPOR/JAK2/STAT3 Axis
Erythropoietin in Lupus: Unanticipated Immune Modulating Effects of a Kidney Hormone
The coexistence of familial Mediterranean fever (FMF) in systemic lupus erythematosus (SLE) patients – A cross sectional study
Prevalence and treatment conditions for hypertension and dyslipidaemia complicated with systemic lupus erythematosus: A multi-centre cross-sectional study
Cognitive dysfunction among people with systemic lupus erythematosus is associated with reduced participation in daily life
Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence
Ultrasound to identify SLE patients with musculoskeletal symptoms who respond best to therapy: The USEFUL longitudinal multicentre study
New therapeutic approaches using hydrogen sulfide donors in inflammation and immune-response
Mood Disorder in Systemic Lupus Erythematosus Induced by Antiribosomal P Protein Antibodies Associated with Decreased Serum and Brain Tryptophan
Comparison of responsiveness of BILAG-2004, SLEDAI-2000 and BILAG Systems Tally (BST)
Voclosporin: First Approval
Relevant domains and outcome measurement instruments in Neuropsychiatric Systemic Lupus Erythematosus: a systematic literature review
Pristane-induced mammary carcinomas
Use of (18)F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography to successfully diagnose central nervous system vasculitis in systemic lupus erythematosus and antiphospholipid syndrome: a case report
A case of systemic lupus erythematosus with marked ascites due to idiopathic non-cirrhotic portal hypertension
Nucleic acids delivered by PEGylated cationic liposomes in systemic lupus erythematosus-prone mice: a possible exacerbation of lupus nephritis in the presence of pre-existing anti-nucleic acid antibodies
Case Report: A Fatal Case of West Nile Virus Meningoencephalomyelitis in a Woman with Systemic Lupus Erythematosus Initially Misdiagnosed as SARS-CoV-2 Infection
Cognitive Impairment in SLE: Mechanisms and Therapeutic Approaches
Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis
Fatigue in patients with systemic lupus erythematosus and neuropsychiatric symptoms is associated with anxiety and depression rather than inflammatory disease activity
Atypical arthritis of the hands : Collagenosis-part 1
Spinal and cerebral hematoma in systemic lupus erythematosus and antiphospholipid syndrome: is drug interaction the culprit?
Cardiac Tamponade during Tocilizumab Therapy in a Patient with Rheumatoid Arthritis and Anti-DNA Antibody Positivity
Winning the Battle after Three Years of Suffering: A Case of a Refractory Pyoderma Gangrenosum Treatment Challenge
Case Report: Kidney Transplantation in a Patient With Acquired Agammaglobulinemia and SLE. Issues and Challenges
Efficacy of allogeneic hematopoietic cell transplantation for autoimmune diseases
Intestinal pseudo-obstruction: Unusual presentation of systemic lupus erythematous
ANTIPHOSPHOLIPID ANTIBODIES DO NOT PREDICT DAMAGE IN SLE PATIENTS IN THE XXI CENTURY. AN OBSERVATIONAL STUDY FROM THE LUPUS-CRUCES COHORT
The Koebner phenomenon on tattoos and piercings in a patient with cutaneous lupus: a case report and review of the literature
Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis
Predictive Biomarker Panel in Proliferative Lupus Nephritis- Two-Dimensional Shotgun Proteomics
Quality Evaluation of the Underlying Evidence in the Updated Treatment Recommendations for Systemic Lupus Erythematosus
Double-Edged Sword: Interleukin-2 Promotes T Regulatory Cell Differentiation but Also Expands Interleukin-13- and Interferon-gamma-Producing CD8(+) T Cells via STAT6-GATA-3 Axis in Systemic Lupus Erythematosus
Integrated Chinese and western medicine for SLE: A protocol for systematic review and meta-analysis
The effects of disease activity on neuronal and behavioural cognitive processes in systemic lupus erythematosus
miR-101-3p negatively regulates inflammation in systemic lupus erythematosus via MAPK1 targeting and inhibition of the NF-kappaB pathway
Stem Cell Therapy as a Treatment for Autoimmune Disease-Updates in Lupus, Scleroderma, and Multiple Sclerosis

An Open Label Study to Evaluate Daratumumab in Participants With Moderate to Severe Systemic Lupus Erythematosus
Overlap syndrome SLE – ANCA associated vasculitis
Anti-tumor necrosis factor-induced lupus in patients with inflammatory bowel disease: a hospital-based cohort study from Korea
4-phenylbutyric acid mediates therapeutic effect in systemic lupus erythematosus: Observations in an experimental murine lupus model
What’s New in the Treatment of Systemic Lupus Erythematosus
Difference of IFI44L methylation and serum IFN-a1 level among patients with discoid and systemic lupus erythematosus and healthy individuals
S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-alpha) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseases
Study of GS-5718 in Participants With Cutaneous Lupus Erythematosus (CLE)
Negativization of antinuclear, anti-dsDNA, and anti-chromatin antibodies after vitamin D supplementation in a lupus patient
Machine Learning for Prediction and Risk Stratification of Lupus Nephritis Renal Flare
Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort
Systemic lupus erythematosus
Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus
Suppressor of cytokine signaling-1 mimetic peptides attenuate lymphocyte activation in the MRL/lpr mouse autoimmune model
Catastrophic antiphospholipid syndrome presented as ruptured papillary muscle during puerperium in a patient with systemic lupus erythematosus
Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
Development of Prediction Models for New Integrated Models and a Bioscore System to Identify Bacterial Infections in Systemic Lupus Erythematosus
DOAC-Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples
Clinical-therapeutic study on the efficacy and safety of thalidomide in the management of discoid lupus erythematosus. A single-centre, retrospective study
Very Severe and Refractory Noninfectious Cystitis in Patients with Systemic Lupus Erythematosus: Potential Role of Rituximab Therapy
Multiple neurological manifestations in a patient with systemic lupus erythematosus and anti-NXP2-positive myositis: A case report
Effects of targeting the transcription factors Ikaros and Aiolos on B cell activation and differentiation in systemic lupus erythematosus
SARS-CoV-2 vaccines in patients with SLE
Hydroxychloroquine: An Old Drug With New Tricks
Estimation of the burden of shielding among a cross-section of patients attending rheumatology clinics with SLE-data from the BSR audit of systemic lupus erythematosus
Deescalation and glucocorticoid-free treatment in SLE
Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice
NK1.1(-) natural killer T cells upregulate interleukin-17 expression in experimental lupus nephritis
Infratentorial onset of progressive multifocal leukoencephalopathy in a patient with systematic lupus erythematosus complicated with lymphoma: a case report
Systemic lupus erythematosus and COVID-19 during pregnancy
Anal cancer and precancerous lesions: a call for improvement
Implementing the DEcision-Aid for Lupus (IDEAL): study protocol of a multi-site implementation trial with observational, case study design : Implementing the DEcision-Aid for Lupus
Adrenal steroidogenesis and ovarian reserve in adult childhood-onset systemic lupus erytematosus patients
Monogenic Lupus with IgA Nephropathy Caused by Spondyloenchondrodysplasia with Immune Dysregulation
Functional Characteristics and Application of Mesenchymal Stem Cells in Systemic Lupus Erythematosus
A novel JAK/ROCK inhibitor, CPL409116, demonstrates potent efficacy in the mouse model of systemic lupus erythematosus
Hepatitis E Viral Association with Autoimmune Hepatitis: A Viral Trigger or Cross-Reactivity
Papulopustular and Ocular Rosacea with an Alleged Coincidence of Cutaneous Lupus Erythematosus: A Case Report
Collapsing FSGS with Concurrent Class 2 and 3 Lupus Nephritis: A Case Report and Review of the Literature
Low-Vacuum Scanning Electron Microscopy to Assess Histopathological Resolution of Class V Lupus Nephritis: A Case Report
Interleukin (IL)-1 family cytokines could differentiate primary immune thrombocytopenia from systemic lupus erythematosus-associated thrombocytopenia
Anti-TNF-alpha-induced lupus syndrome : Two case reports and review of current literature
Which patients with systemic lupus erythematosus in remission can withdraw low dose steroids? Results from a single inception cohort study
Amino Acid Metabolism in Lupus
Independent associations of lymphopenia and neutropenia in patients with systemic lupus erythematosus: a longitudinal, multinational study
Eculizumab therapy on a patient with co-existent lupus nephritis and C3 mutation-related atypical haemolytic uremic syndrome: a case report
Systemic Lupus Erythematosus and COVID-19
Interventions for cutaneous disease in systemic lupus erythematosus
Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar() Gel) for Persistently Active Systemic Lupus Erythematosus
Patient Experience With Fatigue and Qualitative Interview-Based Evidence of Content Validation of The FACIT-Fatigue in Systemic Lupus Erythematosus
Activated low-density granulocytes in peripheral and intervillous blood and neutrophil inflammation in placentas from SLE pregnancies
Prognostic significance of hypertension at the onset of lupus nephritis in Chinese patients: prevalence and clinical outcomes
Subepithelial Autoimmune Bullous Dermatoses Disease Activity Assessment and Therapy
Treatment of neuropsychiatric systemic lupus erythematosus: clinical challenges and future perspectives
Revised ISN/RPS 2018 classification of lupus renal pathology predict clinical remission
Kikuchi-Fujimoto Disease: Report of a Case with Progression to Lupus Nephritis
The impact of SARS-CoV-2 coronavirus infection in patients with systemic lupus erythematosus from a single center in Catalonia
Vascular Inflammation and Dysfunction in Lupus-Prone Mice-IL-6 as Mediator of Disease Initiation
Dysregulated CD38 Expression on Peripheral Blood Immune Cell Subsets in SLE
Circulating Free DNA and Its Emerging Role in Autoimmune Diseases
Lipidomics Revealed Aberrant Metabolism of Lipids Including FAHFAs in Renal Tissue in the Progression of Lupus Nephritis in a Murine Model
CX3CR1 might be a promising predictor of systemic lupus erythematosus patients with pulmonary fibrosis
Gastrointestinal and hepatic involvement in paediatric systemic lupus erythematosus
Severe Vaso-Occlusive Retinopathy in Systemic Lupus Erythematosus: A Case Series
The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old Drug
PEGylated Serp-1 Markedly Reduces Pristane-Induced Experimental Diffuse Alveolar Hemorrhage, Altering uPAR Distribution, and Macrophage Invasion
Medium versus high initial prednisone dose for remission induction in lupus nephritis: A propensity score matched analysis
Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus
Nailfold capillary abnormalities in childhood-onset systemic lupus erythematosus: a cross-sectional study compared with healthy controls
One-year prospective nerve conduction study of thalidomide neuropathy in lupus erythematosus: Incidence, coasting effect and drug plasma levels
Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic)
RNA tape sampling in cutaneous lupus erythematosus discriminates affected from unaffected and healthy volunteer skin
A Novel Inflammatory Dendritic Cell That Is Abundant and Contiguous to T Cells in the Kidneys of Patients With Lupus Nephritis
Severe pulmonary arterial hypertension and massive ascites in a patient with systemic lupus erythematosus and secondary Sjogren’s syndrome
Cutaneous Lupus Erythematosus In Children
Treatment of exostosin 1-associated membranous lupus nephritis with multiple low doses of rituximab: A case report
Pyoderma gangrenosum and cobalamin deficiency in systemic lupus erythematosus: a rare but non fortuitous association
Roles of leptin on the key effector cells of rheumatoid arthritis
Renal tubular distal acidosis: nephrocalcinosis as initial diagnosis.
Psychopathology in paediatric systemic lupus erythematosus
Medication adherence of patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis Considering the Psychosocial Factors, Health Literacy and Current Life Concerns of Patients
Evolution of kidney antibody secreting cells molecular signature in lupus patients with active nephritis upon immunosuppressive therapy
Two shared immune cell signatures stratify patients with Sjogren’s syndrome and systemic lupus erythematosus with potential therapeutic implications
Exploiting Rational Assembly to Map Distinct Roles of Regulatory Cues during Autoimmune Therapy
HLA-DRB1(*)04 as a Risk Allele to Systemic Lupus Erythematosus and Lupus Nephritis in the Malay Population of Malaysia
Downregulated Serum Exosomal miR-451a Expression Correlates With Renal Damage and Its Intercellular Communication Role in Systemic Lupus Erythematosus
Pneumocystis jirovecii pneumonia in systemic lupus erythematosus: a nationwide cohort study in Taiwan
Why is a paediatric respiratory specialist integral to the paediatric rheumatology clinic?
A novel potential target of IL-35-regulated JAK/STAT signaling pathway in lupus nephritis
Niclosamide suppresses the expansion of follicular helper T cells and alleviates disease severity in two murine models of lupus via STAT3
Resolution of calcinosis using bisphosphonates in overlap syndrome – a case report
Interferon alpha Enhances B Cell Activation Associated With FOXM1 Induction: Potential Novel Therapeutic Strategy for Targeting the Plasmablasts of Systemic Lupus Erythematosus
Case Report: Complete Remission of C1q Nephropathy Treated With a Single Low-Dose Rituximab, a Reality or Coincidence?
Clinical disease activity and flare in SLE: Current concepts and novel biomarkers
Belimumab for systemic lupus erythematosus
Belimumab: a step forward in the treatment of systemic lupus erythematosus
Novel signatures associated with systemic lupus erythematosus clinical response to IFN-alpha/-omega inhibition
Severe retinal vasculitis in systemic lupus erythematosus leading to vision threatening paracentral acute middle maculopathy
Patient and provider perceptions of a novel cognitive functioning report for patients with systemic lupus erythematosus: a qualitative study
Atypical Presentation of Pediatric Systemic Lupus Erythematosus Complicated by Cryptococcal Meningitis

Extracorporeal cardiopulmonary resuscitation for the treatment of amlodipine overdose in a pediatric patient
A Fatal Case of Diffuse Alveolar Hemorrhage in the Setting of Systemic Lupus Erythematosus: A Case Report and Review of Noninfectious Causes of Acute Pulmonary Hemorrhage in Adults
An integrated analysis of lncRNA and mRNA expression profiles in the kidneys of mice with lupus nephritis
Psychosis in Systemic Lupus Erythematosus (SLE): 40-year experience of a specialist centre
“It is good to have a target in mind”: Qualitative views of patients and parents informing a treat to target clinical trial in JSLE
Exposure-Response Analysis for Selection of Optimal Dosage Regimen of Anifrolumab in Patients With Systemic Lupus Erythematosus
Seizures in systemic lupus erythematosus: A scoping review
A Systematic Review of the Literature on Systemic Lupus Erythematosus
Actinic cheilitis may resemble oral lichenoid-type lesions or discoid lupus erythematosus
Distribution of IgG subclass anti-nuclear antibodies (ANAs) in systemic lupus erythematosus
Childhood-onset systemic lupus erythematosus with trisomy X and the increased risk for bone complications: a case report
Perioperative Management of Rheumatic Disease and Therapies
Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome
Assessment of SLE activity for acute clinical decision-making: use of a colour-coded threat-level approach for the non-rheumatologist
Rapamycin alleviates renal damage in mice with systemic lupus erythematosus through improving immune response and function
Novel biomarkers for lupus nephritis in the “OMICS” era
Improvement of lupus-associated fatigue with modafinil: Report of two cases
Managing Cardiovascular Risk in Patients with Rheumatic Disease
NOD-like receptors in autoimmune diseases
A case of Stappia indica-induced relapsing peritonitis confirmed by 16S ribosomal RNA gene sequencing analysis in a patient undergoing continuous ambulatory peritoneal dialysis
Long-term therapeutic effects of multi-target therapy in a patient with membranous lupus nephritis: An interesting repeat kidney biopsy case
Triamcinolone
Elevated urinary IL-36gamma in patients with active lupus nephritis and response to treatment
Risk factors for mortality of diffuse alveolar hemorrhage in systemic lupus erythematosus: a systematic review and meta-analysis
Antiphospholipid antibody syndrome-associated renal thrombotic microangiopathy improved not with rivaroxaban but with warfarin in a systemic lupus erythematosus patient without lupus nephritis
Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trials
Black-blood magnetic resonance imaging suggesting central nervous system vasculitis in moyamoya syndrome associated with systemic lupus erythematosus
Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study
Discoid lupus erythematosus solely involving the eyelids: case report and literature review
Efficacy of belimumab in two serologically distinct high disease activity subgroups of patients with systemic lupus erythematosus: post-hoc analysis of data from the phase III programme
Systemic Lupus Erythematosus in Children and Young People
Intracranial hypertension secondary to systemic lupus erythematosus
Safety considerations when using drugs in pregnant patients with systemic lupus erythematosus
Management of Lupus Nephritis
Role of Microneedling in Atrophic Post-Acne Scars: An Experience from a Tertiary Care Hospital
Effect of plasma exosomes on endothelial cell tight junction proteins in SLE patients with immune thrombocytopenia
Mortality Among Minority Populations with Systemic Lupus Erythematosus, Including Asian and Hispanic/Latino Persons – California, 2007-2017
Systemic Lupus Erythematosus and Its Association with Hemophagocytic Syndrome as an Initial Manifestation
A multicenter blinded preclinical randomized controlled trial on Jak1/2 inhibition in MRL/MpJ-Fas(lpr) mice with proliferative lupus nephritis predicts low effect size
Sexual dimorphism in immunometabolism and autoimmunity: Impact on personalized medicine
Clinical characteristics and CT manifestations of invasive pulmonary aspergillosis in hospitalised patients with systemic lupus erythematosus
Correlation between the clinical remission and histological remission in repeat biopsy findings of quiescent proliferative lupus nephritis
Breastfeeding in women affected by systemic lupus erythematosus: Rate, duration and associated factors
Anti-glomerular Basement Membrane Disease with Antiphospholipid Syndrome
Duration of antibiotic therapy in systemic lupus erythematosus patients with hospital-acquired bacterial pneumonia in eastern China
Patchy Alopecia in a Patient with Rheumatoid Arthritis: A Practical Application of Trichoscopy
Experience with milatuzumab, an anti-CD74 antibody against immunomodulatory macrophage migration inhibitory factor (MIF) receptor, for systemic lupus erythematosus (SLE)
Sudden visual loss in a patient with systemic lupus erythematosus caused by a combination of the disease itself and drug toxicity.
Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID-19 Epidemic.
[Therapeutic de-escalation in systemic lupus erythematosus in remission].
Evolution of COVID-19 in patients with autoimmune rheumatic diseases.
Neonatal lupus presenting as a non-specific rash in primary care.
Non-central serous chorioretinopathy in a patient with systemic lupus erythematosus and hydroxychloroquine retinopathy.
[Effects of the COVID-19 quarantine on patients with rheumatoid arthritis and systemic lupus erythematosus].
Correlation between the clinical remission and histological remission in repeat biopsy findings of quiescent proliferative lupus nephritis.
Breastfeeding in women affected by systemic lupus erythematosus: Rate, duration and associated factors.
Anti-glomerular Basement Membrane Disease with Antiphospholipid Syndrome.
Patchy Alopecia in a Patient with Rheumatoid Arthritis: A Practical Application of Trichoscopy.
Toll-Like Receptors Regulate the Development and Progression of Renal Diseases.
Duration of antibiotic therapy in systemic lupus erythematosus patients with hospital-acquired bacterial pneumonia in eastern China.
Sexual and mental health of woman suffering from selected connective tissue diseases: an original paper.
Clinical characteristics and CT manifestations of invasive pulmonary aspergillosis in hospitalised patients with systemic lupus erythematosus.
Impact of novel coronavirus infection in patients with uveitis associated with an autoimmune disease: result of the COVID-19-GEAS patient survey.
Pemphigus Erythematosus: A Case Series from A Tertiary Academic Center and Literature Review.
Sexual dimorphism in immunometabolism and autoimmunity: Impact on personalized medicine.
Serine Phosphorylation of the STAT1 Transactivation Domain Promotes Autoreactive B Cell and Systemic Autoimmunity Development.
Omeprazole-Induced Subacute Cutaneous Lupus Erythematosus.
Antiphospholipid antibodies in patients with coronavirus disease 2019 infection hospitalized in conventional unit.
Systemic Lupus Erythematosus and Its Association with Hemophagocytic Syndrome as an Initial Manifestation.
Adult-diagnosed Chronic Granulomatous Disease: The Need to Increase Awareness.
A multicenter blinded preclinical randomized controlled trial on Jak1/2 inhibition in MRL/MpJ-Faslpr mice with proliferative lupus nephritis predicts low effect size.
Anti-TNF Rechallenge After Infliximab Induced Lupus in Crohn’s Disease.
Elevated urinary IL-36γ in patients with active lupus nephritis and response to treatment.
Risk factors for mortality of diffuse alveolar hemorrhage in systemic lupus erythematosus: a systematic review and meta-analysis.
Black-blood magnetic resonance imaging suggesting central nervous system vasculitis in moyamoya syndrome associated with systemic lupus erythematosus.
Corticosteroids are the major contributors to the risk for serious infections in autoimmune disorders with severe renal involvement.
Antiphospholipid antibody syndrome-associated renal thrombotic microangiopathy improved not with rivaroxaban but with warfarin in a systemic lupus erythematosus patient without lupus nephritis.
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review.
Improvement of lupus-associated fatigue with modafinil: Report of two cases.
IRF5 inhibitor shows promise in mouse models of SLE.
Managing Cardiovascular Risk in Patients with Rheumatic Disease.
NOD-like receptors in autoimmune diseases.
Efficacy of moderately dosed etoposide in macrophage activation syndrome – hemophagocytic lymphohistiocytosis (MAS-HLH).
A case of Stappia indica-induced relapsing peritonitis confirmed by 16S ribosomal RNA gene sequencing analysis in a patient undergoing continuous ambulatory peritoneal dialysis.
Long-term therapeutic effects of multi-target therapy in a patient with membranous lupus nephritis: An interesting repeat kidney biopsy case.
Libman-Sacks endocarditis and associated cerebrovascular disease: The role of medical therapy.
Treat-to-target in systemic lupus erythematosus: Where are we?
Foreign body episcleral suture granulomas mimicking nodular anterior scleritis.
CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS
Association between Optic Neuritis and Inflammatory Bowel Disease: A Population-Based Study.
Management of Lupus Nephritis.
Role of Microneedling in Atrophic Post-Acne Scars: An Experience from a Tertiary Care Hospital.
Neonatal lupus erythematosus presenting with rash, thrombocytopenia compounded by cytomegalovirus colonisation: a diagnostic dilemma.
Acute lupus pneumonitis as the initial presentation of systemic lupus erythematosus.
[Thrombocytopenia and thromboses in a young woman].
Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower.
UHRF1 downregulation promotes T follicular helper cell differentiation by increasing BCL6 expression in SLE.
Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus.
Efficacy of belimumab in two serologically distinct high disease activity subgroups of patients with systemic lupus erythematosus: post-hoc analysis of data from the phase III programme.
[Intracranial hypertension secondary to systemic lupus erythematosus].

Systemic Lupus Erythematosus in Children and Young People.
Expanding the Role of Complement Therapies: The Case for Lupus Nephritis.
Advances in Membranous Nephropathy.
All-cause hospitalizations and mortality in systemic lupus erythematosus in the US: results from a national inpatient database.
Complementary Effects of Carbamylated and Citrullinated LL37 in Autoimmunity and Inflammation in Systemic Lupus Erythematosus.
Lupus manifestations in children with primary immunodeficiency diseases: Comprehensive phenotypic and genetic features and outcome.
Acute Tracheal Necrosis After Intubation in a Childhood Onset Systemic Lupus Erythematosus.
The ALPHA Project: Establishing consensus and prioritisation of global community recommendations to address major challenges in lupus diagnosis, care, treatment and research.
Real-World Experience of Safety of Mycophenolate Mofetil in 119 Japanese Patients with Systemic Lupus Erythematosus: A Retrospective Single-Center Study.
Medication adherence: a qualitative exploration of the experiences of adolescents with systemic lupus erythematosus.
Complications of tuberculous meningitis in magnetic resonance imaging in a patient with systemic lupus erythematosus.
γ heavy chain disease presenting in a patient with systemic lupus erythematosus.
[Application and safety of hydroxychloroquine in chronic disease among children].
Kingella kingae Intrauterine Infection: An Unusual Cause of Chorioamnionitis and Miscarriage in a Patient with Undifferentiated Connective Tissue Disease.
Within-trial economic analysis of flare data from the BLISS-SC trial of subcutaneous belimumab in systemic lupus erythematosus.
Lupus miliaris disseminatus faciei with complete response to isotretinoin.
Early predictors of renal outcome in patients with proliferative lupus nephritis: a 36-months cohort study.
Systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis overlap syndrome in a 77-year-old man: A case report.
Natural killer cells in inflammatory autoimmune diseases.
Long-term Health Consequences of Endometriosis – Pathways and Mediation by Treatment.
Characteristics and Outcomes of Critically Ill Pediatric Patients with Posterior Reversible Encephalopathy Syndrome.
Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid
Evaluation of DOAC Filter, a new device to remove direct oral anticoagulants from plasma samples.
The glycocalyx presents a sweet new target in lupus nephritis.
Adding belimumab improves lupus nephritis.
SARS-CoV-2 and Systemic Lupus Erythematosus.
Mitral Valve Repair for Isolated Libman-Sacks Endocarditis in a Patient with Primary Antiphospholipid Syndrome.
[An updated advance of autoimmune hepatitis in children].
Autoantibodies to Annexin A2 and cerebral thrombosis: Insights from a mouse model.
Predictors of Initial Hydroxychloroquine Receipt among Medicaid Beneficiaries with Incident Systemic Lupus Erythematosus.
Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort.
Taurine attenuates the damage of lupus nephritis mouse via inactivation of the NF-κB pathway.
Hypertension in a patient with medullary sponge kidney: A case report.
Childhood-Onset Systemic Lupus Erythematosus: Southeast Asian Perspectives.
Safety and clinical activity of atacicept in the long-term extension of the Phase IIb ADDRESS II study in systemic lupus erythematosus.
Predominant tubulointerstitial lupus nephritis with preceding pernicious anemia.
Vagus nerve stimulation in musculoskeletal diseases.
Clinicopathological features and outcomes of SLE patients with renal injury characterised by thrombotic microangiopathy.
Chloroquine: autophagy inhibitor, antimalarial, bitter taste receptor agonist in fight against COVID-19, a reality check?
SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy-Is there a link?
Lupus and the Lungs: The Assessment and Management of Pulmonary Manifestations of Systemic Lupus Erythematosus.
Socioeconomic status at diagnosis influences the incremental direct medical costs of systemic lupus erythematosus: A longitudinal population-based study.
Advances in ANCA-associated vasculitis and lupus nephritis.
Are new treatments for lupus nephritis on the horizon?
BLISS in the Treatment of Lupus Nephritis.
Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups.
A Multianalyte Assay Panel With Cell-Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology-Classified Lupus.
Pentacyclic triterpene compounds from loquat leaves reduce skin inflammation and epidermal hyperplasia in psoriasis via inhibiting the Th17 cells.
Ureteritis associated with systemic lupus erythematosus: a case report.
Freiberg’s Infarction as the First Clinical Presentation of Sneddon Syndrome.
[Epstein-Barr virus (Herpesviridae: Gammaherpesvirinae: Lymphocryptovirus: Human gammaherpesvirus 4): replication strategies].
Initial Hydroxychloroquine Monotherapy in Systemic Lupus Erythematosus: Report of Three Cases.
Association of Rituximab Use With Adverse Events in Children, Adolescents, and Young Adults.
B Cell Aberrance in Lupus: the Ringleader and the Solution.
Sirolimus Treatment Of Patients With SLE
Medication Adherence in Chinese Patients With Systemic Lupus Erythematosus.
Sleep quality and clinical and psychological manifestations in women with mild systemic lupus erythematosus activity compared to women with fibromyalgia: A preliminary study.
B cell-intrinsic TLR9 expression is protective in murine lupus.
E4BP4-mediated inhibition of T follicular helper cell differentiation is compromised in autoimmune diseases.
Risk factors for severity of thrombocytopenia in full term infants: a single center study.
Quinacrine, an Antimalarial Drug with Strong Activity Inhibiting SARS-CoV-2 Viral Replication In Vitro.
Outcome of clinical and subclinical myocardial injury in systemic lupus erythematosus – A prospective cohort study.
Voclosporin: a novel calcineurin inhibitor without impact on mycophenolic acid in patients with SLE.
The Effect of Adalimumab in Korean Patients with Refractory Noninfectious Uveitis.
Pregnancy outcomes following maternal treatment with rituximab prior to or during pregnancy: a case series.
Development of a Set of Lupus-Specific, Ambulatory Care-Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study.
Autoimmune polyendocrine syndrome type 4 with systemic lupus erythematosus and anti-phospholipid syndrome.
Functional Lipids in Autoimmune Inflammatory Diseases.
Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers.
Surgical repair of a giant pulmonary artery aneurysm that caused severe left bronchial obstruction.
Impact of Limited Health Literacy on Patient-Reported Outcomes in Systemic Lupus Erythematosus.
Clinical Team Perspectives on the Psychosocial Aspects of Transition to Adult Care for Patients With Childhood-Onset Systemic Lupus Erythematosus.
Extracellular Vesicles in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Functions and Applications.
Recent Advances in Lupus B Cell Biology: PI3K, IFNγ, and Chromatin.
Concomitant primary hyperparathyroidism and systemic lupus erythematosus: coincidence or not? A new case report.
Survey of coyotes, red foxes and wolves from Wyoming, USA, for Echinococcus granulosus s. l.
Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: a case series.
Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis, and rheumatoid arthritis.
Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis.
Hydroxychloroquine in systemic and auto-immune diseases: where are we now?
Belimumab in Lupus Nephritis.
Belimumab in Lupus Nephritis.
Belimumab in Lupus Nephritis. Reply.
Pediatric systemic lupus erythematosus with lupus anticoagulant hypoprothrombinemia syndrome-A case series with review of literature.
Self-perceived quality of life of primary antiphospholipid syndrome patients using vitamin K antagonist.
A longitudinal multiethnic study of biomarkers in systemic lupus erythematosus: Launching the GLADEL 2.0 Study Group.
Improving medication adherence in patients with lupus nephritis.
Induction and maintenance therapy of lupus nephritis: an obituary.
High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry.
NETosis in Rheumatic Diseases.
Post-translational modifications in T cells in systemic erythematosus lupus.
T Cell Abnormalities in the Pathogenesis of Systemic Lupus Erythematosus: an Update.
[Belimumab as add-on treatment in lupus nephritis (summary of the BLISS-LN trial)].
[Systemic lupus erythematosus].
Synergetic Interaction of HLA-DRB1*07 Allele and TNF-Alpha - 863 C/A Single Nucleotide Polymorphism in the Susceptibility to Systemic Lupus Erythematosus.
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease.
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review.
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications.
Scleroderma Renal Crisis in a Case of Mixed Connective Tissue Disease Treated Successfully with Angiotensin-Converting Enzyme Inhibitors.
A Case of Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis Overlap Syndrome.

Association between MRI findings and patient-reported outcomes in patients with rheumatoid arthritis in clinical remission and at relapse.
Hydralazine induced lupus nephritis after prolonged exposure.
Immunostimulatory Endogenous Nucleic Acids Perpetuate Interface Dermatitis-Translation of Pathogenic Fundamentals Into an In Vitro Model.
Regulation of Toll-like receptor-mediated inflammatory response by microRNA-152-3p-mediated demethylation of MyD88 in systemic lupus erythematosus.
[Rheumatology update 2020: the focus was on Covid-19].
Multiple pathways of type 1 interferon production in lupus: the case for amlexanox.
A New Peracetylated Oleuropein Derivative Ameliorates Joint Inflammation and Destruction in a Murine Collagen-Induced Arthritis Model via Activation of the Nrf-2/Ho-1 Antioxidant Pathway and Suppression of MAPKs and NF-κB Activation.
EQ-5D-3L full health state discriminates between drug and placebo in clinical trials of systemic lupus erythematosus.
Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE
Lupus in the 21st century.
Lupus nephritis: clinical presentations and outcomes in the 21st century.
Cutaneous drug eruptions including serum sickness-like reaction, symmetrical drug-related intertriginous and flexural exanthema, and drug-induced lupus.
Adverse Reactions Induced by Minocycline: A Review of Literature.
Systemic lupus erythematosus manifestation following COVID-19: a case report.
QTc interval prolongation in patients with systemic lupus erythematosus treated with hydroxychloroquine.
Legionella pneumophila as a cause of cavitary lung disease in systemic lupus erythematous.
Resolution of huge thrombi in bilateral ventricles caused by severe lupus cardiomyopathy.
Association of complement C3d receptor 2 genotypes with the acquisition of HIV infection in a trial of recombinant glycoprotein 120 vaccine.
Use of a Modified Classic BT Shunt in a Patient With Multiple Conduit Obstructions With Positive Lupus Anticoagulant.
A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE.
Lupus versus dermatomyositis: the hands say it all.
Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.
Mathematical processing is affected by daily but not cumulative glucocorticoid dose in patients with systemic lupus erythematosus.
Pentraxin 3: A promising therapeutic target for autoimmune diseases.
Numbness and Weakness in a Patient With Systemic Lupus Erythematosus.
SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression.
Vogt-Koyanagi-Harada Disease and Systemic Lupus Erythematosus Occurring during Adalimumab Therapy for Ulcerative Colitis.
Rigorous Plasma Microbiome Analysis Method Enables Disease Association Discovery in Clinic.
Transcatheter Aortic Valve Implantation in Patients with Connective Tissue Disease.
Emerging B-Cell Therapies in Systemic Lupus Erythematosus.
Stage one adenocarcinoma of uterine cervix in a patient with systemic lupus erythematosus – a clinical case.
From TTP to Glomerulonephritis: A Lifetime of Lupus.
Raised Plasma Levels of Asymmetric Dimethylarginine Are Associated with Pathological Type and Predict the Therapeutic Effect in Lupus Nephritis Patients Treated with Cyclophosphamide.
Tofacitinib-induced subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis.
Prognostic analysis of antibody typing and treatment for antiphospholipid syndrome-related recurrent spontaneous abortion.
Remission in SLE-do DORIS criteria match the treating physician’s judgment? A cross sectional study to assess reasons for discordance.
Algorithm for calculating high disease activity in SLE.
Genome-wide association study on Northern Chinese identifies KLF2, DOT1L and STAB2 associated with systemic lupus erythematosus.
Late onset of subacute cutaneous lupus erythematosus following pembrolizumab therapy.
Hydroxychloroquine blood levels in stable lupus nephritis under low dose (2-3 mg/kg/day): 12-month prospective randomized controlled trial.
Lupus erythematosus: Significance of dermatologic findings.
Subacute cutaneous lupus erythematosus induced by PD-1 Inhibitor therapy: two case reports and literature review.
Longitudinally Extensive Transverse Myelitis in a Lupus-Neuromyelitis Optica Overlap.
Tubercular meningitis in patients with systemic lupus erythematosus: clinical characteristics, risk factors, and outcomes of 10 patients.
Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.
Tuberculous arthritis of the ankle joint masquerading as rheumatoid arthritis in a patient with lupus nephritis.
PREVALENCE OF THE ABCB1-1Δ GENE IN NONDOMESTIC SPECIES OF THE CANIDAE FAMILY.
Membranous nephropathy: current understanding of various causes in light of new target antigens.
Artemisinin analogue SM934 protects against lupus-associated antiphospholipid syndrome via activation of Nrf2 and its targets.
Cryopreservation of Grey Wolf (Canis lupus) Testicular Tissue.
Efficacy of Intense Pulsed Light in the Treatment of Facial Telangiectasia in Systemic Lupus Erythematosus
Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom.
Negative Pressure Wound Therapy With Instillation and Dwell Time Used to Treat Pyoderma Gangrenosum: A Case Report.
Risk Factors for Short-Term Complication After Open Reduction and Internal Fixation of Ankle Fractures: Analysis of a Large Insurance Claims Database.
Juvenile-onset multifocal osteonecrosis in systemic lupus erythematosus: A case report.
Successful treatment of subdural hemorrhage and retinal hemorrhage in childhood-onset systemic lupus erythematosus associated with thrombocytopenia: Case report.
Dihydroartemisinin attenuated the symptoms of mice model of systemic lupus erythematosus by restoring the Treg/Th17 balance.
Mitral Valve Mass in a Patient Suspected of Systemic Lupus: Tumor, Endocarditis or Both?
Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
Neonatal lupus erythematosus – practical guidelines.
Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry.
Persistent deficiency of mucosal-associated invariant T cells during dermatomyositis.
Young-Onset Ischemic Colitis: A Condition of Elusive Etiology Frequently Associated With Immune Dysregulation.
Clinical characteristics of systemic lupus erythematosus with chylothorax and/or chylous ascites: An analysis of 15 cases in China.
Subacute cutaneous lupus erythematosus in a patient with Sjögren’s syndrome taking terbinafine for onychomycosis.
Maternal and Fetal Outcomes in Systemic Lupus Erythematosus Pregnancies.
Refractory dermatomyositis-systemic lupus erythematosus overlap syndrome and response to tofacitinib.
Alkaline-Encrusted Pyelitis Causing Renal Failure in a Transplant Kidney: Treatment with Percutaneous Nephrolithotomy and Urinary Acidification.
Retrospective Analysis of the Factors Affecting Growth Parameters in Turkish Children With Systemic Lupus Erythematosus.
Rituximab – The first twenty years.
When POTS is the tip of the iceberg: Rare cases of dysautonomia as a possible manifestation of another disorder.
Concomitant Diagnosis of Fibromyalgia and Ankylosing Spondylitis: Relation to Clinical Features and Plasma Pentraxin -3 Level.
Urinary MCP-1 and TWEAK as non-invasive markers of disease activity and treatment response in patients with lupus nephritis in South Africa.
New EULAR/ACR 2019 SLE Classification Criteria: defining ominosity in SLE.
Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’.
Clinical improvement of cardiac function in a patient with systemic lupus erythematosus and heart failure with preserved ejection fraction treated with belimumab.
The readiness of pediatric rheumatology patients and their parents to transition to adult-oriented treatment.
Why is a paediatric respiratory specialist integral to the paediatric rheumatology clinic?
Response to: ‘Patients with lupus are not protected from COVID-19: a comment’ by Sawalha, ‘No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit’ by Romão et al and ‘SLE patients are not immune to COVID-19: importance of sending the right message across’ by Goyal.
MAIT cells, their biological and medical significance.
Network pharmacology modeling identifies synergistic interaction of therapeutic and toxicological mechanisms for Tripterygium hypoglaucum Hutch.
The Main Challenges in Systemic Lupus Erythematosus: Where Do We Stand?
Concentrated autologous bone marrow aspirate transplantation versus conservative treatment for corticosteroid-associated osteonecrosis of the femoral head in systemic lupus erythematosus.
Lupus podocytopathy: a newly emerging nonimmune complex mediated nephropathy associated with systemic lupus erythematosus.
Clinical practice guidelines and recommendations for the management of patients with systemic lupus erythematosus: a critical comparison.
Cytomegalovirus in Indian systemic lupus erythematosus patients: troublemaker or onlooker?
Limbic encephalitis in a patient with systemic lupus erythematosus successfully treated with high-dose glucocorticoids and intravenous cyclophosphamide therapy: the potential pathogenicity of anti-glutamate receptor antibodies.
Hydroxychloroquine Mitigates the Production of 8-Isoprostane and Improves Vascular Dysfunction: Implications for Treating Preeclampsia.
Involvement of RAGE and Oxidative Stress in Inflammatory and Infectious Skin Diseases.
Impact of first wave of SARS-CoV-2 infection in patients with Systemic Lupus Erythematosus: Weighting the risk of infection and flare.
How a discerning cytological examination can aid in the diagnosis of infectious diseases: case reports.
Efficacy of Fractional Er:YAG Laser in Lupus Erythematosus Scars
Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers.
Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus.
Tumoral calcinosis in systemic lupus erythematosus associated with fat necrosis.
[Clinical Features and Risk Factors of Systemic Lupus Erythematosus Complicated with Cytomegalovirus Infection].
Childhood granulomatous periorificial dermatitis: case report and review of the literature.
The role of Stim1 in the progression of lupus nephritis in mice.
New findings associated with presumptive systemic lupus erythematosus in a kitten.
Porphyria cutanea tarda exacerbation as a paraneoplastic syndrome in vaginal cancer resolved with chemoradiation.

Prevalence of osteoporosis in patients with systemic lupus erythematosus: A multicenter comparative study of the World Health Organization and fracture risk assessment tool criteria.
Formulation and stability study of hydroxychloroquine sulfate oral suspensions.
[Toxic hydroxychloroquine-induced cardiomyopathy complicating systemic lupus treatment].
The impact of autoimmune systemic inflammation and associated medications on male reproductive health in patients with chronic rheumatological, dermatological, and gastroenterological diseases: A systematic review.
Electron microscopy study of 496 cases of lupus nephritis: A single-center experience.
A novel therapeutic approach using the Zipper method to treat chorea in a pediatric-onset systemic lupus erythematosus patient.
Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK.
How do systemic lupus erythematosus patients with very-long disease duration present? Analysis of a monocentric cohort.
Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine.
RITUXILUP Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF
Risk factors associated with adverse pregnancy outcomes in patients with new-onset systemic lupus erythematosus during pregnancy.
Onset of subacute cutaneous lupus erythematosus after the initiation of immune checkpoint inhibitor therapy of cancer.
Immune responses to azacytidine in animal models of inflammatory disorders: a systematic review.
Transplantation-mediated alloimmune thrombocytopenia successfully treated by retransplantation.
Successful treatment of severe interstitial pneumonia by removal of circulating autoantibodies: a case series.
Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients.
Interleukin-22 and connective tissue diseases: emerging role in pathogenesis and therapy.
Current status of use of high throughput nucleotide sequencing in rheumatology.
Systemic Lupus Erythematosus: Perinatal Outcomes in Patients Treated With and Without Hydroxychloroquine.
Inhibition of B cell activation following in vivo co-engagement of B cell antigen receptor and Fcγ receptor IIb in non-autoimmune-prone and SLE-prone mice.
Interferon-directed therapies for the treatment of systemic lupus erythematosus: a critical update.
COVID-19, rheumatic diseases and immune dysregulation-a perspective.
The Roles of Orphan G Protein-Coupled Receptors in Autoimmune Diseases.
Consequences of insurance denials among U.S. patients prescribed repository corticotropin injection (Acthar® Gel) for nephrotic syndrome.
Impact of Antimalarial Adherence on Mortality among Patients with Newly Diagnosed Systemic Lupus Erythematosus: A Population-based Cohort Study.
The complex relationship between C4b Binding Protein, warfarin and antiphospholipid antibodies.
A Study Evaluating the Effects of GLPG3970 Given as Oral Treatment for 12 Weeks in Adults With Systemic Lupus Erythematosus
Low ambient temperature increases hospital re-admissions for systemic lupus erythematosus in humid subtropical region: a time series study.
Macrophage Migration Inhibitory Factor (MIF) and Its Homologue d-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus.
A trial of antithrombotic therapy in patients with refractory migraine and antiphospholipid antibodies: A retrospective study of 75 patients.
The influence of obesity on hydroxychloroquine blood levels in lupus nephritis patients.
D-mannose ameliorates autoimmune phenotypes in mouse models of lupus.
Shared development of targeted therapies among autoimmune and inflammatory diseases: a systematic repurposing analysis.
Higher Hydroxychloroquine Blood Levels Are Associated with Reduced Thrombosis Risk in Systemic Lupus Erythematosus.
A retrospective review of the adverse effects of biological therapy and reasons for its discontinuation in a resource-limited setting.
Refractory palmo-plantar Discoid Lupus Erythematosus successfully treated with Mycophenolate Mofetil: unusual localization and literature review.
Total plaque area and plaque echogenicity are novel measures of subclinical atherosclerosis in patients with systemic lupus erythematosus.
Anti-NuMA antibodies: clinical associations and significance in patients with primary Sjögren’s syndrome or systemic lupus erythematosus.
Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week long therapy in patients with SLE.
Ileocolic intussusception caused by mass-forming fibro-granulation from healed ulcer masquerading as small bowel lipoma.
[Advances in induction therapy drugs of lupus nephritis for children].
Generation of systemic lupus erythematosus patient-derived induced pluripotent stem cells from blood.
Patient and parent perspectives on transition from paediatric to adult healthcare in rheumatic diseases: an interview study.
Immune Cell-Stromal Circuitry in Lupus Photosensitivity.
[Change of diagnosis and diagnostic category in patients with juvenile idiopathic arthritis within 7 years of follow-up].
Modular gene analysis reveals distinct molecular signatures for cutaneous lupus patient subsets.
B cell depletion in murine lupus using cytotoxic T lymphocytes in vivo: Feasibility and benefit.
B7-H3: A promising therapeutic target for autoimmune diseases.
Anti-CD2 Antibody-Coated Nanoparticles Containing IL-2 Induce NK Cells That Protect Lupus Mice via a TGF-β-Dependent Mechanism.
Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
Hydroxychloroquine and maintenance immunosuppression use in kidney transplant recipients: Analysis of linked US registry and claims data.
Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis.
The Effect of Mycophenolate Mofetil as First-Line Therapy on the Timing of Urine Protein-to-Creatinine Ratio Reduction in Immunosuppressant-Naive Patients With Lupus Nephritis at a Single Center.
Immunotherapies application in active stage of systemic lupus erythematosus in pregnancy: A case report and review of literature.
Clinical Images: Hydroxychloroquine-associated mucous labial pigmentation in a patient with systemic lupus erythematosus improving under topical treatment with tacrolimus.
Predicting lupus flares: epidemiological and disease related risk factors.
The latest in systemic lupus erythematosus-accelerated atherosclerosis: related mechanisms inform assessment and therapy.
Cellular aspects of the pathogenesis of lupus nephritis.
Mobile health technologies for the management of rheumatic diseases: a systematic review of online stores in Brazil.
COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases.
Rosai-Dorfman-Destombes Disease as First Manifestation of Systemic Lupus Erythematosus.
Spermatic vein thrombosis with lupus anticoagulant, a cause of acute inguinal pain: a case report.
Hemocoagulative post-operative changes after laparoscopic surgery compared to open surgery: the role of lupus anticoagulant.
Anti-neutrophil properties of natural gingerols in models of lupus.
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis.
National Analysis of Coronary Artery Bypass Grafting in Autoimmune Connective Tissue Disease.
Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach.
Discovery of BIIB068: A Selective, Potent, Reversible Bruton’s Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases.
COVID-19 infection in patients with systemic lupus erythematosus: Data from the Asia Pacific Lupus Collaboration.
A Peculiar Case of Small Bowel Stricture in a Coronavirus Disease 2019 Patient with Congenital Adhesion Band and Superior Mesenteric Vein Thrombosis.
Innovative use of concentrated growth factors combined with corticosteroids to treat discoid lupus erythematosus alopecia: A case report.
From incomplete to complete systemic lupus erythematosus; A review of the predictive serological immune markers.
Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: A systematic review.
Corticosteroid dosing and opioid use are high in patients with SLE and remain elevated after belimumab initiation: a retrospective claims database analysis.
IL-23/IL-17 axis in the pathogenesis and treatment of systemic lupus erythematosus and rheumatoid arthritis.
Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway.
Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management.
Computational Studies of Hydroxychloroquine and Chloroquine Metabolites as Possible Candidates for Coronavirus (COVID-19) Treatment.
Resorption of immune deposits in membranous lupus nephritis following rituximab vs conventional immunosuppressive treatment.
Systematic review of safety and efficacy of belimumab in treating immune-mediated disorders.
Predictors of unsuccessful hydroxychloroquine tapering and discontinuation: Can we personalize decision-making in systemic lupus treatment?
Beta Cell Function is Disrupted in Patients with Systemic Lupus Erythematosus.
Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2.
Thymoquinone in autoimmune diseases: Therapeutic potential and molecular mechanisms.
Evaluation of corneal safety in systemic lupus erythematosus patients undergoing long-term hydroxychloroquine treatment.
Total Glucosides of Peony Protect Cardiomyocytes against Oxidative Stress and Inflammation by Reversing Mitochondrial Dynamics and Bioenergetics.
Clinical Observation of COVID-19 in a Patient With an Acquired Humoral Deficiency Secondary to Chemotherapeutic Agents.
COVID-19 in children treated with immunosuppressive medication for kidney diseases.
Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus
Antithyroid Drug-Induced Lupus Erythematosus and Immunoglobulin A Deficiency.
Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform.
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study.
Safety, Tolerability, and Pharmacokinetics of PF-06823859, an Anti-Interferon β Monoclonal Antibody: A Randomized, Phase I, Single- and Multiple-Ascending-Dose Study.
Oxidative stress-induced aberrant lipid metabolism is an important causal factor for dysfunction of immunocytes from patients with systemic lupus erythematosus.
Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients With Systemic Lupus Erythematosus.
Belimumab in lupus nephritis.
Linear cutaneous lupus erythematosus in children-report of two cases and review of the literature: A case report.
Understanding patient-provider discordance in adolescents with lupus: The role of pain and antidepressant medication use.
The Effect of Biological Agents on Antinuclear Antibody Status in Patients with Psoriasis: A Single-Center Study.

Secondary Membranous Nephropathy. A Narrative Review.
Childhood Systemic Lupus Erythematosus; a Rare Multisystem Disorder: Case Report of a 3-year-old Girl with Oral Involvement as a Primary Sign.
Successful hydroxychloroquine treatment in a patient with systemic lupus erythematosus-associated nailfold capillary abnormalities.
Systemic lupus erythematosus symptom clusters and their association with patient-reported outcomes and treatment: Analysis of real-world data.
STING-dependent induction of lipid peroxidation mediates intestinal ischemia-reperfusion injury.
De novo lupus nephritis during treatment with belimumab.
Bilateral ear lobe infiltration: an unusual presentation of lupus vulgaris.
Erratum to 16th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends.
Liquid Chromatographic Methods for COVID-19 Drugs, Hydroxychloroquine and Chloroquine.
Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double-blind Phase Ib study.
Basophils and IgE contribute to Mixed Connective Tissue Disease development.
Lung Cancer Immunotherapy in Transplant Patients and in Patients With Autoimmune Diseases.
CD95/Fas and metastatic disease: What does not kill you makes you stronger.
Kikuchi-Fujimoto disease preceded by lupus erythematosus panniculitis: do these findings together herald the onset of systemic lupus erythematosus?
CD74 auto-antibodies display little clinical value in Chinese Han population with axial spondyloarthritis.
Glomerular Disease and Pregnancy.
Discovery of M5049: A Novel Selective TLR7/8 Inhibitor for Treatment of Autoimmunity.
VDAC1 in the diseased myocardium and the effect of VDAC1-interacting compound on atrial fibrosis induced by hyperaldosteronism.
Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, Function.
Enhanced Fatty Acid Synthesis Leads to Subset Imbalance and IFN-γ Overproduction in T Helper 1 Cells.
IL-Y Aggravates Murine Chronic Graft-Versus-Host Disease by Enhancing T and B Cell Responses.
New therapeutic approaches in systemic lupus erythematosus.
B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE).
Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus.
MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus and Atopic Dermatitis.
Xanthogranulomatous pleuritis – An unusual presentation of tuberculosis.
Monitoring of anticoagulation in thrombotic antiphospholipid syndrome.
Cryptococcemia According to Immune Status: An Analysis of 65 Critical Cases.
Hepatocellular adenoma(s) arising in nodular regenerative hyperplasia in a patient with systemic lupus erythematosus.
Coxiella burnetii Endocarditis in a Patient with Systemic Lupus Erythematosus: A Case Report of a Diagnostic Challenge.
Neutrophil Activation and Neutrophil Extracellular Trap Formation in Dialysis Patients.
Comparison of effectiveness of topical Tacrolimus 0.1% vs topical Halobetasol Propionate 0.05% as an add-on to oral Hydroxychloroquine in Discoid Lupus Erythematosus.
The place of sphingosine-1-phosphate modulators in the therapy of inflammatory bowel diseases
Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: a Danish nationwide cohort study.
Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy Showing Thrombotic Microangiopathy.
Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study.
Effects and interferences of emicizumab, a humanized bispecific antibody mimicking activated factor VIII cofactor function, on lupus anticoagulant assays.
Therapeutic effects of soluble human leukocyte antigen G2 isoform in lupus-prone MRL/lpr mice.
Risk of herpes zoster in the Japanese population with immunocompromising and chronic disease conditions: Results from a claims database cohort study, from 2005 to 2014.
Primary Sjögren’s Syndrome and Cardiovascular Disease.
Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus.
Application of the 2019 European League Against Rheumatism/American College of Rheumatology systemic lupus erythematosus classification criteria in clinical practice: a single center experience.
Patient-Reported Lupus Flare Symptoms Are Associated with Worsened Patient Outcomes and Increased Economic Burden.
What is the appropriate anticoagulation strategy for thrombotic antiphospholipid syndrome?
Extraction of DNA from plastinated tissues.
Elective Termination of Pregnancy in Autoimmune Rheumatic Diseases: Experience From Two Databases.
Peripheral B Cell Subsets in Autoimmune Diseases: Clinical Implications and Effects of B Cell-Targeted Therapies.
Spectrum of biopsy proven renal diseases in Central China: a 10-year retrospective study based on 34,630 cases.
Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay.
Lupus nephritis-related issues during COVID-19 pandemic quarantine.
Higher serum levels of autotaxin and phosphatidylserine-specific phospholipase A1 in patients with lupus nephritis.
Tocilizumab and its usage for skin diseases.
Analysis of Trans-Ancestral SLE Risk Loci Identifies Unique Biologic Networks and Drug Targets in African and European Ancestries.
Lung Cancer Survival in Patients With Autoimmune Disease.
Reduction in SLEDAI is associated with improved arterial stiffness in systemic lupus erythematosus.
CD62L on blood basophils: a first pre-treatment predictor of remission in severe lupus nephritis.
Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: A population-based cohort study.
Improving eye screening practice among pediatric rheumatology patients receiving hydroxychloroquine.
Systemic lupus erythematosus-related acute pancreatitis.
Systemic lupus erythematosus: The search for the ideal biomarker.
Advances in Microbiome Detection Technologies and Application in Antirheumatic Drug Design.
Genetic variant CFH rs6677604 might play a protective role in lupus nephritis.
Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL).
Simultaneous Presentation of Parvovirus B19 Infection and Systemic Lupus Erythematosus in a Patient: Description and Review of the Literature.
Survival and prognostic factors of lung cancer patients with preexisting connective tissue disease: a retrospective cohort study.
A panel of urinary proteins predicts active lupus nephritis and response to rituximab treatment.
The role of neuraminidase in TLR4-MAPK signaling and the release of cytokines by lupus serum-stimulated mesangial cells.
Myocardial Infarction in Systemic Lupus Erythematosus – the Sex Specific Risk Profile.
Immune Cell Landscape Identification Associates Intrarenal Mononuclear Phagocytes With Onset and Remission of Lupus Nephritis in NZB/W Mice.
Systemic erythematous lupus after treatment of multiple sclerosis with alemtuzumab.
Skin-Associated B Cells in the Pathogenesis of Cutaneous Autoimmune Diseases-Implications for Therapeutic Approaches.
Non-infective supraglottitis: two cases of unusual aetiology.
Ovarian antibodies among SLE women with premature menopause after cyclophosphamide.
Urinary soluble VCAM-1 is a useful biomarker of disease activity and treatment response in lupus nephritis.
A glance upon Epigenetic and COVID-19.
Cutaneous Kikuchi disease-like inflammatory pattern without lymph node involvement is associated with systemic disease and severe features in lupus erythematous: A case-control study.
BTK inhibition modulates multiple immune cell populations involved in the pathogenesis of immune mediated nephritis.
Clinical Review Report: Belimumab (Benlysta): (GlaxoSmithKline Inc.): Indication: Indicated in addition to standard therapy for reducing disease activity in adult patients with active, autoantibody-positive systemic lupus erythematosus
Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus.
Common causes of hair loss – clinical manifestations, trichoscopy and therapy.
Regulatory effect of glutathione on treg/Th17 cell balance in allergic rhinitis patients through inhibiting intracellular autophagy.
Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs.
Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors.
The management of neuropsychiatric lupus in the 21st century: still so many unmet needs?
Treatment targets in SLE: remission and low disease activity state.
The patient’s perspective: are quality of life and disease burden a possible treatment target in systemic lupus erythematosus?
Treatment of severe thrombocytopenia associated with systemic lupus erythematosus in pregnancy with eltrombopag: A case report and literature review.
Long-term remission in patients with systemic lupus erythematosus.
The Type II anti-CD20 Antibody Obinutuzumab (GA101) is More Effective than Rituximab at Depleting B Cells and Treating Disease in a Murine Lupus Model.
Intestinal Pseudo-Obstruction as the Initial Clinical Presentation in Systemic Lupus Erythematosus: A Rare and Severe Disorder.
Innate Immunity and Biological Therapies for the Treatment of Sjögren’s Syndrome.
Treatment of immune-mediated cytopenias in patients with primary immunodeficiencies and immune regulatory disorders (PIRDs).
Successful treatment by mycophenolate mofetil of subacute progressive interstitial lung disease associated with systemic lupus erythematosus.
A woman with systemic lupus erythematosus, multiple pregnancy complications, and cerebral infarction who was only positive for phosphatidylserine-dependent antiprothrombin antibodies.
Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study.
Evans’ Syndrome: From Diagnosis to Treatment.
What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment?
IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus.
Sodium Butyrate Ameliorates Gut Microbiota Dysbiosis in Lupus-Like Mice.
Identification of a recurrent pattern of false-positivity by Luminex HLA MHC class I single antigen bead testing.

Platelet proteome changes in dogs with congestive heart failure.
IgA autoantibodies directed against self DNA are elevated in cystic fibrosis and associated with more severe lung dysfunction.
Factors Associated with Rapid Progression to End Stage Kidney Disease in Lupus Nephritis.
Tuberculosis in patients with systemic lupus erythematosus: a 37-year longitudinal survey-based study.
Clinical features and outcomes from the Singapore Sjögren’s syndrome study.
Study of M5049 in Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE) Participants
Low-dose 17α-ethinyl estradiol (EE) exposure exacerbates lupus renal disease and modulates immune responses to TLR7/9 agonists in genetically autoimmune-prone mice.
Small molecule inhibition of human cGAS reduces total cGAMP output and cytokine expression in cells.
A novel BAFF antagonist, BAFF-Trap, effectively alleviates the disease progression of systemic lupus erythematosus in MRL/lpr mice.
New Benefits of Hydroxychloroquine in Pregnant Women with Systemic Lupus Erythematosus: A Retrospective Study in a Tertiary Centre.
Bach2 overexpression represses Th9 cell differentiation by suppressing IRF4 expression in systemic lupus erythematosus.
Diffuse Alveolar Haemorrhage in Systemic Lupus Erythematosus Patients.
Association of Traditional Chinese Medicine Use With Adherence to Prescribed Western Rheumatic Medications Among Chinese American Patients: A Cross-Sectional Survey.
Pharmacokinetics of Belimumab in Children With Systemic Lupus Erythematosus.
Response to: ‘Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine by Mathian et al’ by Notz et al.
Gut Microbiota and Bacterial DNA Suppress Autoimmunity by Stimulating Regulatory B Cells in a Murine Model of Lupus.
Releasing the brakes: a case report of pulmonary arterial hypertension induced by immune checkpoint inhibitor therapy.
BAFF 60-mer, and Differential BAFF 60-mer Dissociating Activities in Human Serum, Cord Blood and Cerebrospinal Fluid.
Necrotizing lymphadenitis : A case report and literature review.
Pharmacoeconomic Review Report: Belimumab (Benlysta): (GlaxoSmithKline Inc.): Indication: Indicated in addition to standard therapy for reducing disease activity in adult patients with active, autoantibody-positive systemic lupus erythematosus
Macrophage activation syndrome in a patient with systemic lupus erythematosus (SLE) and dual viremia.
Protein A immunoadsorption combination with immunosuppressive therapy improves neuropsychiatric systemic lupus erythematosus: A case report.
Q-fever prosthetic valve endocarditis in a patient with SLE and antiphospholipid antibody syndrome.
Employing a latent variable framework to improve efficiency in composite endpoint analysis.
Retinal and choroidal thickness changes in systemic lupus erythematosus patients: a longitudinal study.
Systemic lupus erythematosus, antiphospholipid syndrome and Hashimoto thyroiditis occurring in a patient with Niemann-Pick disease: a second case.
Belimumab is Able to Induce a Significant Improvement of Joint Activity Status in Patients Diagnosed with Systemic Lupus Erythematosus: Results From a 12-Month Longitudinal Study.
Combining miR-23b exposure with mesenchymal stem cell transplantation enhances therapeutic effects on EAE.
Zanubrutinib in Participants With Active Proliferative Lupus Nephritis
Suppression of systemic lupus erythematosus in NZBWF1 mice infected with Hymenolepis microstoma.
Investigating lupus retention in care to inform interventions for disparities reduction: an observational cohort study.
Systemic lupus erythematosus gastrointestinal involvement: a computed tomography-based assessment.
Lupus Nephritis and Chronic Kidney Disease.
Learning to listen: how empathetic engagement with patients can help overcome reproductive injustice.
A Study to Assess the Safety and Tolerability, PK and Efficacy of KPG-818 in Mild to Moderate SLE Patients
Anti-tumor necrosis factor (TNF)-induced lupus in a patient with hidradenitis suppurativa.
Case Series of Chronic Inflammatory Rheumatic Disease Patients Infected by Coronavirus Disease 2019 (COVID-19).
Clinical Outcomes of Hip Arthroscopy in Patients With Systemic Inflammatory Diseases Compared With Matched Controls at a Minimum of 2-Year Follow-Up.
Severe mitral valve regurgitation secondary to Libman-Sacks endocarditis.
A case of acute myelogenous leukemia characterized by arterial and venous thrombosis.
Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosus.
Anti-Tyro3 IgG Associates with Disease Activity and Reduces Efferocytosis of Macrophages in New-Onset Systemic Lupus Erythematosus.
Lupus Anticoagulant in Patients with Covid-19. Reply.
Long-term safety and efficacy of anifrolumab in adults with systemic lupus erythematosus: results of a phase 2 open-label extension study.
A Comparison Of Mycophenolate Mofetil And Cyclophosphamide As Lupus Nephritis Induction Therapy.
Impact of systemic factors in shaping the periodontal microbiome.
NCS 613, a PDE4 inhibitor, by increasing cAMP level suppresses systemic inflammation and immune complexes deposition in kidney of MRL/lpr lupus- prone mice.
Belimumab in Lupus Nephritis: New Trial Results Arrive During an Exciting Time for Therapeutics.
Long-term efficacy and safety outcomes of lenalidomide for cutaneous lupus erythematosus: a multicenter retrospective observational study of 40 patients.
Fracture risk in systemic lupus erythematosus patients over 28 years.
Hemolytic Disease of the Fetus and Newborn Caused by Maternal Autoantibody with Mimicking Anti-E Specificity.
Plaque-like Cutaneous Lupus Mucinosis as the First Sign of Systemic Lupus Erythematosus.
Towards a practical management of fatigue in systemic lupus erythematosus.
Anifrolumab for the treatment of active systemic lupus erythematosus: a meta-analysis of randomized controlled trials.
The use of anti-TNF-alpha therapies for patients with Systemic Lupus Erythematosus. Where are we now?
Pulmonary hypertension in connective tissue diseases, new evidence and challenges.
Musculoskeletal Ultrasound in Systemic Lupus Erythematosus: Systematic Literature Review by the Lupus Task Force of the OMERACT Ultrasound Working Group.
An Elusive Case of Mycosis Fungoides: Case Report and Review of the Literature.
Late-onset systemic lupus erythematosus: characteristics and outcome in comparison to juvenile- and adult-onset patients-a multicenter retrospective cohort.
Isoradiotopic response of discoid lupus after radiotherapy: A case report and review of the literature.
Cryptococcal meningitis in patients with lupus nephritis.
Neutrophil Extracellular Traps in Autoimmunity and Allergy: Immune Complexes at Work.
Systemic lupus erythematosus in the setting of HIV-1 infection: a longitudinal analysis.
Targeted knockdown of Kv1.3 channels in T lymphocytes corrects the disease manifestations associated with systemic lupus erythematosus.
The spectrum of lupus myocarditis: from asymptomatic forms to cardiogenic shock.
Multi-pronged approach to enhance education of children and adolescents with lupus, caregivers, and healthcare providers in New Jersey: Needs assessment, evaluation, and development of educational materials.
[AN UNUSUAL DIAGNOSIS OF CHRONIC URTICARIA].
Recent Clinical and Preclinical Studies of Hydroxychloroquine on RNA Viruses and Chronic Diseases: A Systematic Review.
Atrial thrombus as a complication of SLE and APS in an 8-year-old child.
Systemic Lupus Erythematosus, Its Impact on Selected Cardiovascular Risk Factors, and Correlation with Duration of Illness: A Pilot Study.
A Case of Prolonged Catatonia Caused by Sjögren’s Syndrome.
Improved non-invasive positron emission tomographic imaging of chemotherapy-induced tumor cell death using Zirconium-89-labeled APOMAB®.
Calcified constrictive pericarditis resulting in tamponade in a patient with systemic lupus erythematosus.
Real-World Effectiveness of Belimumab in the Treatment of Systemic Lupus Erythematosus: Pooled Analysis of Multi-Country Data from the OBSErve Studies.
Analysis of the Clinical Effects of the Combination of Mycophenolate Mofetil with Either Tacrolimus or Cyclophosphamide.
Allergic diseases and long-term risk of autoimmune disorders: longitudinal cohort study and cluster analysis.
[Pyoderma gangrenosum and systemic lupus erythematosus: A rare association].
Systemic Lupus Erythematosus.
Pulmonary hypertension associated with congenital heart block and neonatal lupus syndrome: A series of four cases.
Relationship between disease activity, organ damage and health-related quality of life in patients with systemic lupus erythematosus: A systemic review and meta-analysis.
Hydroxychloroquine suppresses interferon-inducible genes and B-cell activating factor in patients with incomplete and new onset systemic lupus erythematosus.
Concerns, healthcare use, and treatment interruptions in patients with common autoimmune rheumatic diseases during the COVID-19 pandemic.
Time-Dependent Changes in Porcelain Aorta and Aortic Stenosis in a Patient with Systemic Lupus Erythematosus.
A case report of hydroxychloroquine-induced auditory and visual hallucination.
Successful Treatment of Urticarial Vasculitis in a Patient With Systemic Lupus Erythematosus With Rituximab.
Long-Term Anticoagulation in Secondary Ischemic Stroke Prevention: The Prospective Multicenter RESTAIC Registry.
Autoimmunity in Segmental Vitiligo.
COVID-19 and Systemic Lupus Erythematosus: Focus on Immune Response and Therapeutics.
Fractalkine mediates lymphocyte inflammation and tubulointerstitial lesions by modifying the Treg/Th17 balance in lupus-prone MRL/lpr mice.
Rare Association of Antiphospholipid Antibody Syndrome, Systemic Lupus Erythematosus and Aortic Dissection: A Striking Presentation with Multi-Organ Failure?
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies.
Early Treatment of Interleukin-33 can Attenuate Lupus Development in Young NZB/W F1 Mice.
Application of procalcitonin, white blood cell count and neutrophil-to-lymphocyte ratio in the diagnosis of systemic lupus erythematosus with a bacterial infection.
Experimental Study of Nanostructured Lipid Carrier in the Treatment of Immune Lupus Nephritis.
Effects of Nano-α-Linolenic Acid and miR-146 on Mice with Viral Myocarditis.
B-cell depletion or belimumab or voclosporin for lupus nephritis?
A Proposed Aeromedical Disposition Flowchart for Systemic Lupus Erythematosus.
Associations of metabolic syndrome in SLE.
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research.
Pharmacokinetics and pharmacogenomics of mycophenolic acid and its clinical correlations in maintenance immunosuppression for lupus nephritis.

Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019.
Prevalence and associated factors of medication nonadherence among Thai patients with systemic lupus erythematosus.
Serum and Urine Monocyte Chemoattractant Protein-1 as A Markers for Lupus Nephritis.
Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring.
Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.
Complement 1q protects MRL/lpr mice against lupus nephritis via inhibiting the nuclear factor-κB pathway.
Corticosteroid associated lupus pancreatitis.
Infusion of anti-DFS70 antibodies prolonged survival of lupus-prone mice.
Extracellular Chromatin Triggers Release of Soluble CEACAM8 Upon Activation of Neutrophils.
Outcome and Prognosis of Patients With Lupus Nephritis Submitted to Renal Transplantation.
Galectin-3 orchestrates the histology of mesentery and protects liver during lupus-like syndrome induced by pristane.
Immunomodulatory Effects of Vitamin D in Pregnancy and Beyond.
Role of the Complement Pathway in Inflammatory Skin Diseases: A Focus on Hidradenitis Suppurativa.
Transplant outcomes in kidney recipients with lupus nephritis, and systematic review.
Systemic lupus erythematosus aggravates atherosclerosis by promoting IgG deposition and inflammatory cell imbalance.
Systemic lupus erythematosus with autoimmune neurological manifestations in a carrier of chronic granulomatous disease – a rare presentation.
Acquired hemophilia A in a woman with systemic lupus erythematosus: A case report and review of literature.
Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis.
Mycophenolic acid, the active form of mycophenolate mofetil, interferes with IRF7 nuclear translocation and type I IFN production by plasmacytoid dendritic cells.
Emerging Technologies to Target Drug Delivery to the Skin – the Role of Crystals and Carrier-Based Systems in the Case Study of Dapsone.
Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.
“Coronavirus could kill me #StayHomeSaveLives”: A content and sentiment analysis of tweets by people with arthritis during COVID-19.
Acute parkinsonism in patients with systemic lupus erythematosus: A case report and review of the literature.
Adverse drug reactions associated with treatment in patients with chronic rheumatic diseases in childhood: a retrospective real life review of a single center cohort.
Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports.
Dorsolateral medullary infarction during skin infection by Stenotrophomonas maltophilia in a patient with triple antiphospholipid antibody positivity: a case-based review.
Neuronal surface P antigen (NSPA) modulates postsynaptic NMDAR stability through ubiquitination of tyrosine phosphatase PTPMEG.
Neurosurgical and neuro-immunological management of IgG4-related hypertrophic sclerosing pachymeningitis. A literature survey and discussion of a unique index case.
Management of Severe Refractory Systemic Lupus Erythematosus: Real-World Experience and Literature Review.
Interferon-stimulated GTPases in autoimmune and inflammatory diseases: promising role for the guanylate-binding protein (GBP) family.
Osteonecrosis of the distal tibia in systemic lupus erythematosus: A rare case report.
Efficacy and safety of rituximab for systemic lupus erythematosus treatment: a meta-analysis.
Side Effects of Chloroquine and Hydroxychloroquine on Skeletal Muscle: a Narrative Review.
Age-Associated B Cells (ABCs) in the Prognosis, Diagnosis and Therapy of Systemic Lupus Erythematosus (SLE).
A Rare Case with Systemic Lupus Erythematosus Manifested by two Different Neurologic Entities; Guillain Barre Syndrome and Posterior Reversible Encephalopathy Syndrome.
Thromboendarterectomy in a patient with Systemic Lupus and antiphospholipid Syndrome, lessons learned from a complex disease interaction.
COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients.
Refractory Urticaria with Raised Antistreptolysin O (ASO) Titer: An Intriguing Case of Adult-Onset Still’s Disease.
Rheumatologists’ perspective on hydroxychloroquine guidelines.
Prediction of hospitalizations in systemic lupus erythematosus using the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI).
The HSP90 Inhibitor, 17-AAG, Influences the Activation and Proliferation of T Lymphocytes via AKT/GSK3β Signaling in MRL/lpr Mice.
Concomitant onset of systemic lupus erythematosus and disseminated histoplasmosis: a case-based review.
Oral isotretinoin for the treatment of dermatologic conditions other than acne: a systematic review and discussion of future directions.
Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance.
Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis.
An unusual case of acute lower gastrointestinal bleeding due to fungal infection.
A Case of Systemic Lupus Erythematosus with Malignant Pleural Mesothelioma in a 42-year Woman.
Transcutaneous auricular vagus nerve stimulation reduces pain and fatigue in patients with systemic lupus erythematosus: a randomised, double-blind, sham-controlled pilot trial.
Diffuse alveolar hemorrhage, a rare presentation of polymyositis.
Impact of hydroxychloroquine on the gestational outcomes of pregnant women with immune system problems that necessitate the use of the drug.
Complement C4A Regulates Autoreactive B Cells in Murine Lupus.
Update on Lupus Nephritis: Looking for a New Vision.
Lupus-like Disease in FcγRIIB-/- Mice Induces Osteopenia.
[Secondary ITP in adults].
[Cytomegalovirus infection in systemic lupus erythematosus patients. A series of 12 case reports and literature review].
Efficacy and safety of rituximab biosimilar in refractory lupus.
Belimumab in the treatment of Portuguese Systemic Lupus Erythematosus patients: a real-life multicenter study.
Response to placebo in non-renal, non-neuropsychiatric systemic lupus erythematosus: a systematic review and pooled analysis.
Catastrophic antiphospholipid syndrome associated with systemic lupus erythematosus: a case-based review.
Twelve-Week Internet-Based Individualized Exercise Program in Adults With Systemic Lupus Erythematosus: Protocol for a Randomized Controlled Trial.
Lupus myocarditis in an octogenarian patient-a case report.
Comparing the Efficacy and Safety of Induction Therapies for the Treatment of Patients with Proliferative Lupus Nephritis in South Africa.
Parvovirus B19 infection mimicking systemic lupus erythematosus, successfully treated with intravenous immune globulin.
Targeted delivery of immunosuppressant in SLE.
[The place of riociguat in the treatment of patients with pulmonary arterial hypertension associated with systemic connective tissue diseases].
Effect of omega-3 fatty acids on systemic lupus erythematosus disease activity: A systematic review and meta-analysis.
Anti-Müllerian hormone in African-American women with systemic lupus erythematosus.
Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients.
Intrarenal injection of mesenchymal stem cell for treatment of lupus nephritis in mice – a pilot study.
Endothelial dysfunction and cardiovascular risk in lupus nephritis: new roles for old players?
Cucurbitacin IIb improved active chromatin-induced systemic lupus erythematosus via balancing the percentage of Th17 and Treg cells.
Lymphocyte subset clustering analysis in treatment-naive patients with systemic lupus erythematosus.
Silica Exposure Differentially Modulates Autoimmunity in Lupus Strains and Autoantibody Transgenic Mice.
Nephritic Syndrome.
Association of AIRE (rs2075876), but not CTLA4 (rs231775) polymorphisms with Systemic Lupus Erythematosus.
TNIP1/ABIN1 and lupus nephritis: review.
Emicizumab-Induced Seronegative Full-House Lupus Nephritis in a Child.
Talaromyces marneffei Infection in Systemic Lupus Erythematosus Patients: Report of Two Cases and Review of the Literature.
Omega-3 Docosahexaenoic Acid (DHA) Impedes Silica-Induced Macrophage Corpse Accumulation by Attenuating Cell Death and Potentiating Efferocytosis.
A Comprehensive Review of Biological Agents for Lupus: Beyond Single Target.
Autoimmunity and SLE: Factual and Semantic Evidence-Based Critical Analyses of Definitions, Etiology, and Pathogenesis.
Fibrinogen-Like Protein 1 Is a Novel Biomarker for Predicting Disease Activity and Prognosis of Rheumatoid Arthritis.
Lupus and NMOSD: The Blending of Humoral Autoimmunity.
Identification of Long Noncoding RNAs lnc-DC in Plasma as a New Biomarker for Primary Sjögren’s Syndrome.
The association between active proliferative lupus nephritis during pregnancy and small for gestational age newborns.
Uric acid as a risk factor for progression to chronic kidney disease in patients with lupus nephritis: results from the KORNET registry.
The gut microbiota of non-treated patients with SLE defines an autoimmunogenic and proinflammatory profile.
A Novel Network Pharmacology Strategy to Decode Mechanism of Lang Chuang Wan in Treating Systemic Lupus Erythematosus.
Milk fat globule epidermal growth factor 8 (MFG-E8) on monocytes is a novel biomarker of disease activity in systemic lupus erythematosus.
Predictors of the start of declining eGFR in patients with systemic lupus erythematosus.
Amiselimod, a sphingosine 1-phosphate receptor-1 modulator, for systemic lupus erythematosus: A multicenter, open-label exploratory study.
Discovery of Small Molecule Drugs Targeting the Biogenesis of microRNA-155 for the Treatment of Systemic Lupus Erythematosus.
Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.
Acute Kidney Injury Caused by Evans Syndrome with Systemic Lupus Erythematosus and Systemic Sclerosis.
Autoimmune Hypophysitis With Systemic Lupus Erythematosus: A Case Report and Literature Review.
SLE: Novel Postulates for Therapeutic Options.
T Cells in Autoimmunity-Associated Cardiovascular Diseases.
Application of LC-MS/MS method for determination of dihydroartemisin in human plasma in a pharmacokinetic study.
Impact of autoimmune cytopenias on severity of childhood-onset systemic lupus erythematosus: A single-center retrospective cohort study.
Atherosclerotic plaque vulnerability is increased in mouse model of lupus.

Clinical profile of osteonecrosis in systemic lupus erythematosus – Experience from a tertiary care centre in South India.
Assessing outcomes in a lupus nephritis cohort over a 40-year period.
Successful treatment of erythematous-squamous disorders of the external auditory canal with tacrolimus and clotrimazole in otic oil: our experience in 25 patients.
Treating Systemic Lupus Erythematosus (SLE): The Impact of Historical Environmental Context on Healthcare Perceptions and Decision-Making in Charleston, South Carolina.
Taxing the brain: a case of neuropsychiatric systemic lupus erythematosus.
Multifactorial aggressive and reversible cardiomyopathy in systemic lupus erythematosus.
Parenteral Bevacizumab for the Treatment of Severe Respiratory Papillomatosis in an Adult Population.
Lupus-like nephritis with positive anti-neutrophil cytoplasmic antibodies and negative antinuclear antibodies.
The utility of urinary biomarker panel in predicting renal pathology and treatment response in Chinese lupus nephritis patients.
Platelets and IgE: Shaping the Innate Immune Response in Systemic Lupus Erythematosus.
Associated clinical factors for serious infections in patients with systemic lupus erythematosus.
Hyaluronic Acid Synthesis Contributes to Tissue Damage in Systemic Lupus Erythematosus.
Trends of Hospital Palliative Care Utilization and Its Associated Factors Among Patients With Systemic Lupus Erythematosus in the United States From 2005 to 2014.
Dialysis in Pregnancy: Role of the Underlying Cause of Renal Failure on Peripartum Outcomes.
Digital Therapeutic Platform for Management of Systemic Lupus Erythematosus.
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.
Type 1 Interferon Gene Signature Promotes RBC Alloimmunization in a Lupus Mouse Model.
Lupus Vulgaris and Lichen Scrofulosorum with Disseminated Tuberculosis.
Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus.
Trabecular Bone Score and Bone Quality in Systemic Lupus Erythematosus Patients.
Bronchiolitis obliterans organizing pneumonia as the pulmonary manifestation of lupus: A review of three cases.
Comment on: Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus: reply.
The association of acute rejection vs recurrent glomerular disease with graft outcomes after kidney transplantation.
A case of γδ T-cell large granular lymphocytic leukemia due to a chronic active Epstein-Barr virus infection in systemic lupus erythematosus.
Nine-test panel has superior sensitivity to detect antiphospholipid antibody syndrome in patients with or without SLE.
Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations.
In Vivo Remodeling of Altered Autophagy-Lysosomal Pathway by a Phosphopeptide in Lupus.
Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials.
Immunomodulatory effects of cytokine-induced expansion of cytotoxic lymphocytes in a mouse model of lupus-like disease.
Clinical significance of soluble interleukin-2 receptor measurement in immune-mediated diseases.
Renal Infiltration as a Primary Presentation of Burkitt Lymphoma Secondary to Systemic Lupus Erythematosus: A Rarity Unto a Rarity.
Case study of tacrolimus as an effective treatment for idiopathic membranous glomerulonephritis in pregnancy.
What about glucocorticoids in primary Sjögren’s syndrome?
A case of systemic sclerosis/lupus overlap syndrome presenting with bilateral cotton wool spots.
Recurrent Stevens-Johnson syndrome in a patient with systemic lupus erythematosus: a case report.
A case of systemic lupus erythematosus in which Cushing’s syndrome caused by adrenal adenoma accidentally occurred during long-term maintenance therapy with corticosteroids.
Atypical femoral fracture associated with delayed union for which the cessation of alendronate and daily administration of teriparatide contributed to fracture healing: histopathological evidence of the enhancement in bone formation parameters.
Autoimmune myelofibrosis associated with systemic lupus erythematosus: a case report.
Concurrent onset of acute lupus myocarditis, pulmonary arterial hypertension and digital gangrene in a lupus patient: a possible role of vasculitis to the rare disorders.
Treatment of psoriatic arthritis complicated by systemic lupus erythematosus with the IL-17 blocker secukinumab and an analysis of the serum cytokine profile.
Clinical presentation of a neuropsychiatric lupus patient with symmetrical basal ganglia lesions containing cytotoxic oedema cores surrounded by vasogenic oedema.
Multifocal osteoarticular tuberculosis in a systemic lupus erythematosus (SLE) patient: a rarity or an underdiagnosed condition?
Successful treatment of refractory acute lupus haemophagocytic syndrome using rituximab: a case report.
Systemic lupus erythematosus with repeated protein-losing enteropathy resulting from different pathological conditions: a case report.
Why thromboembolism occurs in some patients with thrombocytopenia and treatment strategies.
The Investigation of the Association of Cutaneous Leishmaniasis in Biopsy Specimens of the Patients with Granulomatous Disease and Skin Cancer Using the Molecular Method.
Value of Urinary Neutrophil Gelatinase-Associated Lipocalin versus Conventional Biomarkers in Predicting Response to Treatment of Active Lupus Nephritis.
STING Mediates Lupus via the Activation of Conventional Dendritic Cell Maturation and Plasmacytoid Dendritic Cell Differentiation.
Prophylactic inhibition of soluble epoxide hydrolase delays onset of nephritis and ameliorates kidney damage in NZB/W F1 mice.
A case of chronic sarcoidosis presenting with lupus pernio.
Prevention of recurrent miscarriage in women with antiphospholipid syndrome: A systematic review and network meta-analysis.
Next stop in the treatment of refractory systemic lupus erythematosus: B-cell targeted combined therapy.
Pediatric catastrophic antiphospholipid syndrome patient evolving to systemic lupus erythematosus.
Candidate drug replacements for quinacrine in cutaneous lupus erythematosus.
Pregnancy outcome in systemic lupus erythematosus patients: a monocentric cohort analysis.
Diagnoses, Outcomes, and Chronicity Predictors of Patients with Secondary Immune Thrombocytopenia: Ten-Year Data from a Hematology Referral Center.
Pharmacokinetics and Pharmacodynamics of JNJ-55920839, an Antibody Targeting Interferon α/ω, in Healthy Subjects and Subjects with Mild-to-Moderate Systemic Lupus Erythematosus.
Anti-IFNαR Mabs for the treatment of Systemic Lupus Erythematosus.
The TLC-NOSF (Technology Lipido-Colloid Plus Nano-Oligo Saccharide Factor) protease inhibitor for the treatment of ulceration in rheumatic disease A case report.
MYSM1 Represses Innate Immunity and Autoimmunity through Suppressing the cGAS-STING Pathway.
Complement Inhibitors in Clinical Trials for Glomerular Diseases.
Antiphospholipid syndrome and infertility.
Choroidal thickness in lupus nephritis.
Septicaemia is associated with increased disease activity and mortality in systemic lupus erythematosus: a retrospective analysis from Taiwan.
COVID-19 in a patient with a flare of systemic lupus erythematosus: a rare case-report.
Health-Related Quality of Life Improvements in Systemic Lupus Erythematosus Derived from a Digital Therapeutic Plus Tele-Health Coaching Intervention: Randomized Controlled Pilot Trial.
IL-38: A novel cytokine in systemic lupus erythematosus pathogenesis.
Mortality in patients with systemic lupus erythematosus and neuropsychiatric involvement: A retrospective analysis from a tertiary referral center in the Netherlands.
Psychotherapy for the Treatment of Acute Musculoskeletal Pain: A Review of Clinical Effectiveness and Guidelines
Acute chloroquine and hydroxychloroquine toxicity: A review for emergency clinicians.
The Emerging Role of Renal Tubular Epithelial Cells in the Immunological Pathophysiology of Lupus Nephritis.
Sustained Remission of Lupus Panniculitis Treated With Hydroxychloroquine in a Patient With Crohn’s Disease: A Case Report.
Pathological RANK signaling in B cells drives autoimmunity and chronic lymphocytic leukemia.
Antiphospholipid syndrome.
Update οn the diagnosis and management of systemic lupus erythematosus.
Comparative analysis of long-term organ damage in patients with systemic lupus erythematosus using belimumab versus standard therapy: a post hoc longitudinal study.
Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus.
Kidney transplantation in systemic lupus erythematosus: Outcomes and prognosis.
EULAR recommendations for a core data set for pregnancy registries in rheumatology.
Evaluating cutaneous lupus disease activity end points and their effects on quality of life as an outcome measure for clinical trials.
Clinical management of Lupus patients during the COVID-19 pandemic.
Radiotherapy for Cervical Cancer in Patients with Systemic Lupus Erythematosus.
Development and exacerbation of pulmonary nontuberculous mycobacterial infection in patients with systemic autoimmune rheumatic diseases.
Complement Activation on Endothelial Cell-Derived Microparticles-A Key Determinant for Cardiovascular Risk in Patients with Systemic Lupus Erythematosus?
Clinical characteristics and prognosis of concomitant systemic lupus erythematosus and primary biliary cholangitis.
A simple and highly efficient method of IFI44L methylation detection for the diagnosis of systemic lupus erythematosus.
Pilocarpine for Sjögren’s Syndrome-Induced Dry Mouth and Dry Eyes: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation.
A Histologic Analysis of a Retrieved Specimen 24 Years after Hemiresurfacing for Avascular Necrosis.
Serum adiponectin levels are associated with presence of carotid plaque in women with systemic lupus erythematosus.
Leveraging Heterogeneity in Systemic Lupus Erythematosus for New Therapies.
Peculiar blood flow profiles among placental chorionic villous vessels of an abnormally thick placenta in a case of systemic lupus erythematosus characterized using microvascular imaging.
Early damage as measured by SLICC/ACR damage index is a predictor of hospitalization in systemic lupus erythematosus (SLE).
Natural history of nonbacterial thrombotic endocarditis treated with warfarin.
The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis.
Centrally Acting Angiotensin-Converting Enzyme Inhibitor Suppresses Type I Interferon Responses and Decreases Inflammation in the Periphery and the CNS in Lupus-Prone Mice.
Niclosamide ethanolamine attenuates systemic lupus erythematosus and lupus nephritis in MRL/lpr mice.
Central Nervous System Vasculitis Secondary to Sarcoidosis: A Rare Case of Lupus Pernio With Complete Occlusion of Right Internal Carotid Artery.
Spectrum of autoimmune bullous diseases among children in Kuwait.
Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis.